Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?

To: David who wrote (2508)	12/15/1997 10:44:00 AM
From: Jaffo	Read Replies (1) \| Respond to of 4676

David: NRI has great products and IMO will not go belly up. New technology generally takes a while to gain acceptance, i.e., the IDX/Orcles product. Part of the strength of NRI is that it is supported by CAI, Unisys, giants companies with long coat-tails. Consequently, NRI will be able to get MONEY. I agree with Randy that in the long run the biometric play is s/w and not h/w. IDX appears to be in a catch up position, i.e., buying BAT for a mere $5M if my recollection serves me correctly. The real question is what did IDX really buy as $5M is not a whole lot of money. Does BAT have any products rivaling NRI? IMO, NRI is so far ahead of everyone in s/w that the No. 2 position belongs to the Market. The Market, such as it is, should start to catch up after the year end sales for tax loss. Jaffo